Angiotensin I converting enzyme (ACE) inhibitory activity of peptides derived from the hydrolysis of sarcoplasmic and myofibrillar porcine proteins by the action of Lactobacillus sakei CRL1862 and Lactobacillus curvatus CRL705 (whole cells + cell free extracts) was investigated at 30°C for 36 h. The protein hydrolysates were subjected to RP-HPLC in order to fractionate the extracts for further evaluation of ACE inhibitory activity. Bioactive fractions were only found from the hydrolysis of sarcoplasmic proteins by both assayed lactobacilli strains. Identification of peptides contained in the bioactive fractions was carried out by tandem mass spectrometry using a nanoLC-ESI-QTOF instrument and the mascot search engine. From the four most active fractions obtained, a total of eighteen and fifty peptides were characterized from L. sakei CRL1862 and L. curvatus CRL705 protein hydrolysates, respectively. The sequence FISNHAY was generated by the proteolytic activity of the two lactobacilli species. Sequence similarity analyses between the peptides identified in this study and those previously identified as ACE inhibitory peptides and detailed in the BIOPEP database were outlined. Results suggest that meat-borne Lactobacillus were able to generate peptides with ACE inhibitory activity, highlighting their potential to be used in the development of functional fermented products.
1.

Introduction
Food proteins have long been recognized for their nutritional and functional properties. Nutritional properties are associated with their amino acid content in conjunction with the physiological utilization of specific amino acids upon digestion and absorption [1, 2] . On the other hand, the functional properties of proteins are related to their contribution to physiochemical and sensory properties of foods [3] . In recent years, a considerable amount of research has also focused on the release of bioactive peptides which are encrypted within the primary structure of food proteins, in view to investigate such peptides as functional food ingredients aimed at health maintenance.
A variety of biologically active peptides derived from food proteins have been identified [4] . Inhibitors of angiotensin I converting enzyme (ACE) have attracted particular attention for their ability to prevent hypertension. Angiotensin I converting enzyme is a dipeptidyl carboxypeptidase [EC 3.4.15.1] that not only catalyzes conversion of angiotensin I to angiotensin II causing hypertension, but also inactivates bradykinin, a vasodilatory peptide [5] . Consequently, those compounds capable to inactivate the activity of this enzyme would generate the opposite effect, i.e. a decrease of blood pressure. Many ACE inhibitor peptides have been isolated from enzymatically digested food proteins such as casein, whey proteins, plant proteins [6] and muscle sources [7] . On the other hand, proteolytic release of bioactive sequences by lactic acid bacteria (LAB) has been debated recently due to the great advantages of using food grade microorganisms to enrich foods with bioactive substances [8] . As reported in the literature, potent ACE inhibitory peptides were produced during milk fermentation or casein proteolysis by lactic acid bacteria proteases [8] [9] [10] however this effect has been poorly documented from meat proteins. Although, a study has been performed on marine proteins, particularly during fermentation of shrimp (Acetes chinensis) with Lactobacillus fermentum SM605 in which three ACE inhibitory peptides were identified [11] .
In this work, L. curvatus CRL705 and L. sakei CRL1862 isolated from traditional Argentinean sausages [12, 13] were used as proteolytic enzyme sources to evaluate the generation of ACE inhibitory peptides from porcine skeletal muscle proteins Muscle foods serve as interesting substrates for investigation into the potential presence of bioactive peptides, specifically ACE inhibitory peptides to design new healthy meat products.
2.
Materials and methods
Bacterial strains and culture conditions
Lactobacillus curvatus CRL705 and Lactobacillus sakei CRL1862 strains from CERELA culture collection, previously isolated from traditional sausages [12, 13] , were used to generate bioactive peptides. The strains were routinely grown in MRS broth (Britania, Argentina) at 30°C for 18 h and then maintained at −80°C in 15% (vol/vol) glycerol. Counts were carried out using Plate Count Agar for total mesophiles and MRS agar for LAB at 30°C during 48 h.
2.2.
Preparation of L. curvatus CRL705 and L. sakei CRL1862 cell suspensions and meat protein extracts Whole-cell (WC) suspensions (150 ml) from L. sakei CRL1862 and L. curvatus CRL705 grown to logarithmic phase were collected by centrifugation (10,000 rpm, 20 min, 4°C), washed twice in 20 mM phosphate buffer (pH 7.0), and resuspended in the same buffer (20% of initial volume). The cell free extracts (CFE) were obtained by the procedure described by Sanz et al. [14] . Meat protein extracts were obtained from porcine longissimus dorsi sarcoplasmic and myofibrillar proteins according to Fadda et al. [15] . The protein contents of sarcoplasmic and myofibrillar extracts determined by the method of Bradford [16] using bovine serum albumin as standard were 2.50 and 0.60 mg/ml, respectively. For both extracts, sterility was confirmed by determining the absence of bacterial growth on Plate Count Agar (Merck, Argentina) incubated overnight at 30°C.
Protein hydrolysis and peptide analysis
For each meat protein extract (sarcoplasmic or myofibrillar) a combination (1:1) of CFE + WC suspension of L. curvatus CRL705 or L. sakei CRL1862, added separately, was used as proteolytic enzyme source. The reaction mixture consisted of 3 ml of each suspension (WC and CFE) aseptically added to 30 ml of protein extract. The mixtures were incubated at 30°C in a shaken water bath and sampled at time 0 h and after 96 h for further analyses. In each case, control samples without the addition of any bacterial enzymes were assayed simultaneously. The extracts with different treatments were centrifuged for 20 min at 14,000 rpm, and the supernatants were collected for the experiments. The analysis of generated peptides was performed by RP-HPLC as follows: 4 ml of each sarcoplasmic or myofibrillar extract was deproteinized with 10 ml of methanol, centrifuged (10,000 rpm, 10 min, 4°C), supernatants concentrated by evaporation to dryness and resuspended in deionized water. Peptide extracts were analyzed at day 0 and after 96 h of incubation, using a 1050 high-performance liquid chromatograph (Agilent, Palo Alto, CA, USA) equipped with a photodiode array detector and manual injector. A 4.6 × 250 mm Symmetry C18 column (Waters, Milford, MA, USA) was used. The mobile phase consisted of solvent A (0.1% trifluoroacetic acid in water) and solvent B (acetonitrile-water-trifluoroacetic acid [60:40:0.085, vol/vol/vol]). The elution was performed as follows: an isocratic phase in 1% solvent B for 5 min, followed by a linear gradient from 1 to 100% solvent B for 55 min, at a flow rate of 1.0 ml/min at 40°C. Peptides were detected at 214 nm.
2.4.
Assay for ACE inhibitory activity
The fractions were collected, dried and re-dissolved in 70 μl of 150 mM Tris-base buffer (pH 8.3). The ACE inhibitory activity of each fraction was measured according to procedures described previously [17] . This assay is based on the ability of ACE to hydrolyze the internally quenched fluorescent sub- 
Elucidation of the peptide sequence by tandem mass spectrometry
Identification of the peptide sequence from fractions exhibiting remarkable ACE inhibitory activity was carried out by MS/MS analysis using an Ultimate Plus/Famos nano LC system (LC Packings, Amsterdam, The Netherlands) and a QSTAR XL hybrid quadrupole-TOF instrument (ABSCIEX, CA, USA) equipped with a nanoelectrospray ion source (Protana, Odense, Denmark). Fractions obtained from RP-HPLC fractionation showing the highest ACE inhibitory activity were concentrated using a speed-vac. Peptides were then desalted using C18 pipette tips and diluted in 60 μl of loading buffer (0.1% of formic acid and 2% of acetonitrile in water). Diluted samples were pre-concentrated on a 0.3 × 5 mm, 3 μm, C18 trap column from LC Packings PepMap (Dionex Company, Amsterdam, The Netherlands) at a flow rate of 40 μl/min and using 0.1% of trifluoroacetic acid (TFA) as mobile phase. After 3 min of pre-concentration, the trap column was automatically switched in-line with a 0.075 × 150 mm, 3 μm, Dionex C18 PepMap column from LC Packings. Mobile phases consisted of solvent A, containing 0.1% formic acid in water and solvent B containing 0.1% formic acid in 95% acetonitrile. Chromatographic conditions were a linear gradient from 95% to 50% solvent A in 30 min at a flow rate of 0.2 ml/min. The column outlet was directly coupled to a nano-eletrospray ion source (Protana, Odense, Denmark) using a 15 μm PicoTip EMITTER SilicaTip needle (New Objective, Massachusetts, USA). The positive TOF mass spectra were recorded on the QSTAR instrument using information dependent acquisition (IDA). TOF MS survey scan was recorded for mass range m/z 350-1800 followed by MS/MS scans of the three most intense peaks. Typical ion spray voltage was in the range of 2.5-3.0 kV, and nitrogen was used as collision gas. Other source parameters and spray position were optimized with a tryptic digest of protein mixture digest (LC Packings; P/N 161088). Interpretation of obtained MS/MS spectra was performed using an in-house 2.3 Mascot search engine version (Matrix Science, London, England) in combination with searches on UniProtKB/Swiss-Prot protein database. Mascot.dll 1.6b25 and ABSciex.DataAccess.Wiff File DataReader.dll were used for importing data to Mascot. Searches were done with the "none" enzyme specificity and a tolerance on the mass measurement of 0.7 Da in MS mode and 0.5 Da for MS/MS ions. Deamidation of Asn-Gln and oxidation of Met were used as variable modifications.
Statistical analysis
Each experiment was performed on two separate replications.
One-way analysis of variance (ANOVA) was used (Minitab Statistic Program, release 8.21; Minitab Inc., Philadelphia, PA, USA).
Results and discussion
Cell counts in pork sarcoplasmic and myofibrillar meat protein extracts, both inoculated with L. sakei CRL1862 or L. curvatus CRL705 (WC + CFE), showed initial numbers of approximately 10 9 CFU/ml. After 96 h of incubation at 30°C, a decline to 8.21 log CFU/ml and undetectable levels for L. sakei CRL1862 were found in sarcoplasmic and myofibrillar extracts respectively, while decreases to 7.41 (sarcoplasmic) and 2.39 (myofibrillar) log CFU/ml were observed for L. curvatus CRL705 (Table 1) . These results are in agreement with those previously reported by Fadda et al. [15] , in which L. curvatus CECT904 and L. sakei CECT4808 (WC + CFE) incubated on sarcoplasmic proteins under similar conditions yielded higher final viabilities than myofibrillar extracts. On the other hand, the combined WC and CFE suspensions inoculated on myofibrillar extracts in this study exhibited the same trend as was reported by Sanz et al. [14] . L. sakei CRL1862 and L. curvatus CRL705 were reported to exert antimicrobial activity [18, 19] . With the aim to use these strains as potential functional cultures in meat products, the evaluation of their protein hydrolytic ability as well as bioactive peptides generation (in particular ACE inhibitory activity) from pork sarcoplasmic and myofibrillar proteins was carried out. A biochemical approach is presented in this work using proteolytic enzymes available in both WC and CFE suspensions with the objective to enhance the proteolytic activity on meat proteins. In fact, CFE from different microorganisms were applied as an additional enzyme source to achieve higher availability of small peptides and free amino acids in dry fermented sausages [20] .
The resulting peptide patterns obtained from the proteolytic activity of L. sakei CRL1862 and L. curvatus CRL705 on sarcoplasmic proteins are shown in Fig. 1 . The RP-HPLC profiles from these extracts showed minor differences between 0 and 96 h in control samples (Fig. 1A,B ) when compared to those inoculated with the combination of WC and CFE from L. sakei CRL1862 (Fig. 1C) and L. curvatus CRL705 (Fig. 1D) . Indeed, inoculated extracts showed great peptide generation between 15 and 40 min and the disappearance of peaks after 45 min in contrast to control samples at 96 h of incubation. It has been reported that peptides rich in hydrophobic amino acids and present in the medium-high retention time region of a chromatogram on C18 reverse phase column may exhibit ACE inhibitory activity [21] . Myofibrillar extracts showed similar results than those for sarcoplasmic protein extracts, since again no significant changes were found between myofibrillar control samples at times 0 and 96 h ( Fig. 2A,B) . During 96 h of incubation with the addition of WC and CFE from L. sakei CRL1862 and L. curvatus CRL705, some new peaks were generated by both organisms like those at 12, 19 and 28 min of retention time (Fig. 2C,D) . However, the generation of peptides from sarcoplasmic proteins was much higher than that from myofibrillar. In coincidence with these results, lactobacilli strains were reported to hydrolyze pork sarcoplasmic proteins while a lack of proteolytic activity was detected on myofibrillar extracts [22] . In contrast, an intense hydrolysis of myofibrillar proteins during fermentation and drying stages of pork sausages using a mixed starter culture (LAB and Staphylococcus strains) was found by Aro Aro et al. [23] and Hughes et al. [24] . When the ACE inhibitory activity was determined, only the hydrolysates derived from sarcoplasmic proteins by the action of L. sakei CRL1862 and L. curvatus CRL705 resulted to be active. Peptides generated by L. sakei CRL1862 from sarcoplasmic extracts after 96 h of incubation showed inhibitory activities toward ACE of 54% ± 2.3 and 50% ± 3.1 in 27 and 32 min fractions, respectively (Fig. 1C) . Also high percentages of inhibition (48% ± 3.4 and 50% ± 2.8) were detected in the fractions eluting at 32 and 34 min from L. curvatus CRL705 hydrolysates (Fig. 1D) . The remaining collected fractions did not exert a remarkable ACE inhibition. Similar ACE inhibitory activities from sarcoplasmic proteins isolated from bovine muscles were found using thermolysin + proteinase A and papain enzymes [25, 26] . In addition, when L. fermentum SM 605 was used as enzyme source on marine proteins, high ACE inhibitory activity particularly during fermentation of marine shrimp (A. chinensis) was obtained [11] . The identification of peptides contained in fractions 27 and 32 ( Fig. 1C) and fractions 32 and 34 (Fig. 1D) was carried out through MS/MS ion search using the Mascot search engine and UniProtKB/Swiss-Prot protein database. Results from peptide sequencing were subjected to a manual evaluation as described by Chen et al. [27] ; the validated sequences explained all the major peaks found in the full MS spectrum. The active ACE inhibitory fractions containing one or more peptides, their respective molecular masses and sequences, are listed in Tables 2 and 3 . A search of potential biological activity that can be derived from the identified peptides was carried out with the BioPep database and by comparison with sequences previously reported [28, 29] . Fraction 27, obtained from sarcoplasmic proteins by the action of L. sakei CRL1862 showed the highest ACE inhibition activity (54%), yielding only one peptide sequence (FISNHAY), whereas a total of 17 peptides were identified from fraction 32 of the same extract. On the other hand, 50 peptides were characterized from the two most active fractions originated by L. curvatus CRL705, 30 from fraction 32 and 20 from fraction 34 (Table 3) . Indeed, both fractions corresponding to a retention time of 32 min were found to be coincident for LAB strains in terms of ACE inhibitory activity; however, as shown in Tables 2 and 3 , the nature of peptides contained in them differs significantly.
In general, all the peptides identified from the 4 analyzed fractions showed a prevalence of hydrophobic and neutral residues in the penultimate and ultimate C-terminal position. It has been reported that at penultimate C-terminal position, aliphatic (V, I, and A), basic (R) and aromatic (Y and F) residues are frequently found in ACE inhibitory peptides, while aromatic (W, Y, and F), proline (P) and aliphatic (I, A, L and M) residues are preferred at the ultimate C-terminal end of peptides [30] . In addition, peptides consisting of 6-14 amino acid residues were identified (Tables 2 and 3 ), which are in coincidence with ACE inhibitory peptides containing this numbers of residues reported by Byun and Kim [31] . Although small peptides (tri or tetra) were described to be more easily absorbed in the intestinal tract than larger peptides [32] , evidence that large peptides could also be absorbed through the small intestine wall of rats was previously reported [33] . In this study, L. sakei CRL1862 as shown in Table 3 was able to generate the unique peptide FISNHAY in fraction 27. The heptapeptide FISNHAY, rather than having a proline residue, has aliphatic (alanine) and aromatic (tyrosine) residues at the penultimate and ultimate C-terminal positions, respectively; this peptide sequence has not yet been found in other protein 
